Loading…
HS

Haleh Saber

FDA
Deputy Director, DHOT/ OHOP/ CDER
Dr. Saber is the Deputy Director in the Division of Hematology Oncology Toxicology (DHOT). In this role, she provides leadership for day-to-day activities, leads and coordinates scientific research, and participates in guidance development. Dr. Saber has extensive industry and regulatory experience. She served as a Subject Matter Expert assisting pharmaceutical companies worldwide in nonclinical drug development and served many roles at the FDA over 15 years, starting as a primary reviewer before becoming a Supervisory Pharmacologist in DHOT. Dr. Saber is recognized for her efforts in establishing acceptable approaches in first-in-human dose selection for new classes of products.